Debode J, De Maeyer K, Perneel M, Pannecoucque J, De Backer G, Höfte M
Department of Crop Protection, Laboratory of Phytopathology, Ghent University, Gent, Belgium.
J Appl Microbiol. 2007 Oct;103(4):1184-96. doi: 10.1111/j.1365-2672.2007.03348.x.
To examine the effect of previously described bacterial antagonists on the viability of Verticillium microsclerotia in vitro and to elucidate the possible modes of action of bacterial strains in the suppression of Verticillium microsclerotia viability.
A microplate assay was developed to test the suppressive effect of well-defined Pseudomonas spp. on the viability of Verticillium microsclerotia in vitro. Experiments using phenazine- and biosurfactant-deficient mutants indicated that biosurfactants and phenazine-1-carboxylic acid play a role in the suppression of microsclerotia viability by Pseudomonas spp. In addition, microsclerotia colonization tests revealed that Pseudomonas spp. are able to colonize the surface of the microsclerotia, but not the inner matrix. Growth response curves showed that the population levels of Pseudomonas spp. increased when they were in the vicinity of Verticillium microsclerotia, indicating that Pseudomonas spp. may utilize nutrients from the microsclerotia for their growth.
Pseudomonas spp. seem to be good candidates for Verticilllium microsclerotia biocontrol. Biosurfactant production is one of the main mechanisms involved in their mode of action.
This line of work may contribute to a better understanding of biological control agents and their working mechanisms.
研究先前描述的细菌拮抗剂对体外黄萎病菌微菌核活力的影响,并阐明细菌菌株抑制黄萎病菌微菌核活力的可能作用方式。
开发了一种微孔板测定法,以测试特定假单胞菌属对体外黄萎病菌微菌核活力的抑制作用。使用吩嗪和生物表面活性剂缺陷型突变体进行的实验表明,生物表面活性剂和吩嗪 -1- 羧酸在假单胞菌属抑制微菌核活力中发挥作用。此外,微菌核定殖试验表明,假单胞菌属能够定殖在微菌核表面,但不能定殖在内部基质中。生长反应曲线表明,当假单胞菌属靠近黄萎病菌微菌核时,其种群水平会增加,这表明假单胞菌属可能利用微菌核中的营养物质进行生长。
假单胞菌属似乎是黄萎病菌微菌核生物防治的良好候选者。生物表面活性剂的产生是其作用方式所涉及的主要机制之一。
这项工作可能有助于更好地理解生物防治剂及其作用机制。